Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study

被引：0
|
作者：
Alireza Minagar
Irena Adamashvili
Roger E Kelley
Eduardo Gonzalez-Toledo
Jerry McLarty
Stacy J Smith
机构：
[1] LSU Health Sciences Center,Department of Neurology
[2] LSU Health Sciences Center,Department of Radiology
[3] LSU Health Sciences Center,Department of Internal Medicine
来源：
Journal of Neuroinflammation | / 4卷
关键词：
Multiple Sclerosis; Multiple Sclerosis Patient; Optic Neuritis; Natalizumab; RRMS Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Neuropsychological effects of Avonex® (interferon-β-1a) in relapsing multiple sclerosis (MS)
    Fischer, JS
    Priore, R
    Jacobs, L
    Cookfair, D
    Rudick, R
    Herndon, R
    Richert, J
    Salazar, A
    Goodkin, D
    Granger, C
    Simon, J
    Grafman, J
    Lezak, M
    O'Reilly, K
    Schacter, M
    Shucard, D
    Davidson, A
    Wende, K
    NEUROLOGY, 1998, 50 (04) : A32 - A33
  • [22] Quality of life in multiple sclerosis:: influence of interferon-β1a (Avonex®) treatment
    Vermersch, P
    de Seze, J
    Delisse, B
    Lamaire, S
    Stojkovic, T
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (05) : 377 - 381
  • [23] Affinity maturation of antibodies against interferon-β in patients with multiple sclerosis treated with interferon β-1a
    Basuroski, I. Dujmovic
    Deisenhammer, F.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S244 - S245
  • [24] The PRISMS study. Interferon-β 1a (Rebif) in intermittent multiple sclerosis [Die PRISMS-studie. Interferon-β 1a (Rebif®) bei schubformiger multipler sklerose]
    Hartung H.-P.
    Flachenecker P.
    Weilbach F.X.
    Rieckmann P.
    Der Nervenarzt, 1999, 70 (2) : 182 - 185
  • [25] AUtoimmunity PRofile in INterferon β-1a treated multiple sclerosis patients.: The AUPRIN study:: comparison of 2 different dosage of subcutaneous interferon-β-1a
    Verdun, E
    Ricci, A
    Cucci, MA
    Barbero, P
    Pipieri, A
    Clerico, M
    Giordano, L
    Delfico, L
    Tassinari, T
    Motti, L
    Paciello, M
    Reggio, A
    Aimo, G
    Durelli, L
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S251 - S251
  • [26] Inosine and interferon β 1a:: preliminary results of a clinical trial in multiple sclerosis
    García, DM
    Marín, M
    López, J
    Arias, M
    Dapena, D
    Alonso-Alonso, M
    Martínez, J
    Vázquez, F
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S272 - S272
  • [27] Interferon-β-1a/interferon-β-1bMultiple sclerosis exacerbation: 9 case reports
    Reactions Weekly, 2012, 1394 (1) : 27 - 27
  • [28] Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis
    Yamaguchi, Hiroki
    Sakai, Kenji
    Goto, Yoshinori
    Yamada, Masahito
    JOURNAL OF NEUROLOGY, 2018, 265 (06) : 1469 - 1471
  • [29] Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosis
    Duddy, ME
    Armstrong, MA
    Crockard, AD
    Hawkins, SA
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (01) : 98 - 109
  • [30] Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis
    Hiroki Yamaguchi
    Kenji Sakai
    Yoshinori Goto
    Masahito Yamada
    Journal of Neurology, 2018, 265 : 1469 - 1471
12345